Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Monday Links

Posted on June 20, 2022July 25, 2022 by John C. Goodman
  • The liberal plantation? Washington, D.C., has the largest gap in racial economic equality, compared to the 50 states. The capital also has the largest median income, homelessness rate, unemployment rate, and labor force participation gaps. Study.
  • Why has health care been relatively unimpacted by general inflation?
  • Poll: One in ten men would like to be cloned
  • Why did Biden agree to let China (and other “developing countries”) steal our intellectual property with respect to Covid vaccines?
  • A column by New York Times’ David Leonhardt made a bold claim: “The death rate for white Americans has recently exceeded the rates for Black, Latino and Asian Americans.” The claim is almost assuredly wrong.
+

HSA-Bashing Study Slammed

Posted on June 18, 2022 by John C. Goodman

32 million people have a Health Savings Account with more than $100 billion in balances. And they love them. They would love them even more if we could dispense with the across-the-board, high deductible requirement and let the account be perfectly flexible with respect to their health insurance.

+

Senators Sanders and Paul Try to Sneak in Drug Reimportation Amendment

Posted on June 17, 2022 by Devon Herrick

Drug reimportation is an attractive idea until you think it though. Importing drugs from abroad would seem to make sense in a global economy. Proponents point to the fact that the United States pays the highest price for drugs of any developed country. U.S. prices are far more than developing countries pay. Opponents correctly point out what you’re importing is other countries’ price controls.

+

Friday Links

Posted on June 17, 2022July 25, 2022 by John C. Goodman
  • AMA To FDA: Allow OTC Birth Control Pill. Something we have favored for years, but don’t stop there!
  • AMA rejects economics: calls for a higher minimum wage. (Pardon us for thinking that the OTC position was based on sound economic reasoning.)
  • How manufacturers manipulate the rules to avert competition from generic competitors – the case of asthma inhalers.
  • How Biden’s policies have undermined his previous vice presidential goal of a “moon shot” to eradicate cancer.
+
  • Previous
  • 1
  • …
  • 198
  • 199
  • 200
  • 201
  • 202
  • 203
  • 204
  • …
  • 213
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom